Different PK profile [Study As­sess­ment]

posted by Helmut Homepage – Vienna, Austria, 2018-02-06 14:28 (2412 d 08:36 ago) – Posting: # 18364
Views: 10,061

Hi ssussu,

❝ […] during the infusion, we found a bubble in the infusion tube. For safety, we have to stop the infusion and expel the bubble in the infusion tube, and this stop takes 5min. And to complete the infusion in 0.5h, we speed up the infusion pump speed.


Be aware that the dose will not be correct since likely you lost a part by flushing the tube. Whether this is really relevant depends on the lost volume / total infusion volume.

❝ We will assessment the PK for this drug by NCA. What's the effect of this situation? Does the Cmax should be excluded? What about the AUC? What should the investigator to do if the same situation (need to stop temporarily or need to change the infusion speed) occurs next time?


I would stop the infusion and exclude the subject. Reasons:
  1. During stop, elimination continues, and
  2. only if you lost nothing (almost impossible) the Cmax and AUC will equal the one with a constant rate infusion.
I don’t see a solution if you will analyze the data by NCA. If you are able to measure the lost volume, you could analyze the data by a PK model correcting the doses and adjusting the infusion rates.
Example: t½ 8 h, infusion interrupted after 15 min for 5 minutes, adjusted infusion rate, no dose lost.

[image]


Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,225 posts in 4,879 threads, 1,652 registered users;
39 visitors (0 registered, 39 guests [including 5 identified bots]).
Forum time: 00:04 CEST (Europe/Vienna)

We absolutely must leave room for doubt
or there is no progress and no learning.
There is no learning without having to pose a question.
And a question requires doubt.
People search for certainty.
But there is no certainty.    Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5